MedPath

JOHN HOPE FRANKLIN CENTER

JOHN HOPE FRANKLIN CENTER logo
🇺🇸United States
Ownership
Private
Established
1838-01-01
Employees
5K
Market Cap
-
Website
http://www.duke.edu
Clinical Trials
Related News

Exercise, Heart Failure, and Type 2 Diabetes

Not Applicable
Withdrawn
Conditions
Heart Failure
Type 2 Diabetes
Interventions
Behavioral: aerobic exercise training
First Posted Date
2014-04-25
Last Posted Date
2023-06-15
Lead Sponsor
Duke University
Registration Number
NCT02122835
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

Dynamics of the Microbiome in the Premature Infant

Completed
Conditions
Infection
First Posted Date
2014-04-24
Last Posted Date
2024-04-12
Lead Sponsor
Duke University
Target Recruit Count
30
Registration Number
NCT02121938
Locations
🇺🇸

Duke University Hospital, Durham, North Carolina, United States

Safety Study of Regorafenib With PF-03446962 to Treat Colorectal Cancer

Phase 1
Completed
Conditions
Colorectal Cancer
Interventions
Biological: PF-03446962
First Posted Date
2014-04-17
Last Posted Date
2019-03-14
Lead Sponsor
Duke University
Target Recruit Count
11
Registration Number
NCT02116894
Locations
🇺🇸

Duke Cancer Center, Duke University Medical Center, Durham, North Carolina, United States

Mobile Sensing of Smoking Behavior

Not Applicable
Completed
Conditions
Smoking
Health
First Posted Date
2014-04-16
Last Posted Date
2014-11-05
Lead Sponsor
Duke University
Target Recruit Count
2
Registration Number
NCT02116283
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

Trial of Neoadjuvant Ipilimumab Followed by Melphalan Via Isolated Limb Infusion for Patients With Unresectable In-transit Extremity Melanoma

Phase 1
Completed
Conditions
Unresectable Melanoma
Interventions
First Posted Date
2014-04-15
Last Posted Date
2018-10-29
Lead Sponsor
Duke University
Target Recruit Count
4
Registration Number
NCT02115243
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

Anti-thrombin III (ATIII) vs Placebo in Children (<7mo) Undergoing Open Congenital Cardiac Surgery

Phase 2
Completed
Conditions
ATIII Deficiency
Interventions
Drug: Anti-thrombin III
Other: Placebo
First Posted Date
2014-04-03
Last Posted Date
2019-11-25
Lead Sponsor
Duke University
Target Recruit Count
45
Registration Number
NCT02103114
Locations
🇺🇸

Duke University, Durham, North Carolina, United States

The Mobile Health Platform

Not Applicable
Completed
Conditions
Hypertension
Diabetes
Obesity
First Posted Date
2014-03-31
Last Posted Date
2017-02-23
Lead Sponsor
Duke University
Target Recruit Count
6
Registration Number
NCT02099513
Locations
🇺🇸

Duke University Medical Center, Pickens Primary Care Clinic, Durham, North Carolina, United States

Older Cancer Caregiver Needs Post Hospital Discharge

Completed
Conditions
Cancer Caregivers of Older Adults
First Posted Date
2014-03-31
Last Posted Date
2015-07-23
Lead Sponsor
Duke University
Target Recruit Count
23
Registration Number
NCT02099526
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

H.O.P.E: Helping Ovarian Cancer Patients Cope

Not Applicable
Completed
Conditions
Palliative Care
Recurrent Ovarian Cancer
Platinum-resistant Ovarian Cancer
Interventions
Other: Structured Palliative Care
Other: Usual Care
First Posted Date
2014-03-18
Last Posted Date
2020-05-13
Lead Sponsor
Duke University
Target Recruit Count
47
Registration Number
NCT02090582
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

🇺🇸

University of North Carolina, Chapel Hill, North Carolina, United States

Health Coaching for Glaucoma Patients

Not Applicable
Completed
Conditions
Glaucoma
Interventions
Behavioral: Health Coach
First Posted Date
2014-03-18
Last Posted Date
2016-03-14
Lead Sponsor
Duke University
Target Recruit Count
9
Registration Number
NCT02090777
Locations
🇺🇸

Duke Eye Center, Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy